Cargando…
Rapid “epiretinal membrane” development following intravitreal bevacizumab for Coats' disease
PURPOSE: To report a case of rapid “epiretinal membrane” (“ERM”) development following intravitreal bevacizumab for juvenile Coats' disease. OBSERVATIONS: A 7-year old boy was followed for four years with asymptomatic stage 2 Coats' disease in his left eye. At age 11, he developed symptoma...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010952/ https://www.ncbi.nlm.nih.gov/pubmed/29942874 http://dx.doi.org/10.1016/j.ajoc.2018.06.002 |